# miR-204 Negatively Regulates HIV-Tat-Mediated Inflammation in Cervical Epithelial Cells via the NF-κB Axis: Insights from an In Vitro Study

**Authors:** Kadambari Akolkar, Vandana Saxena

PMC · DOI: 10.3390/cells15020117 · Cells · 2026-01-09

## TL;DR

This study shows that miR-204 reduces inflammation caused by HIV's Tat protein in cervical cells by targeting the NF-κB pathway.

## Contribution

The study identifies miR-204-5p as a novel regulator of HIV-Tat-induced inflammation via the TLR7/NF-κB axis in cervical epithelial cells.

## Key findings

- Tat stimulation increases inflammatory mediators and activates TLR7/NF-κB in cervical cells.
- miR-204-5p overexpression reduces Tat-induced inflammation and targets NF-κB directly.
- HIV-1 Tat downregulates miR-204-5p, contributing to cervical inflammation.

## Abstract

Despite antiretroviral therapy, HIV proteins, such as Tat, persist in tissues, driving chronic inflammation. Cervical inflammation in females not only accelerates HIV progression but also increases the risk of other STIs; hence, understanding the underlying factors/regulators is vital. However, Tat-induced cervical inflammation and its regulation are hitherto poorly understood, which we investigated using TZM-bl cells. Tat stimulation in these cervical epithelial cells significantly increased the expression of various inflammatory mediators, including cytokines (IL-1β, TNF-α, IL-6, IL-17a, GM-CSF), chemokines (MIP-1α, MIP-1β), adhesion molecules (ICAM-1, P-Selectin, E-Selectin), and ROS. Further upregulation of inflammatory mediators (NF-κB, IRAK-4) along with TLR7 was observed in Tat-stimulated cells. Interestingly, Tat stimulation decreased miR-204-5p expression in these cells, suggesting a role in regulating Tat-mediated inflammatory processes. Using a gain-of-function approach, we further observed that the overexpression of miR-204-5p reduced the expression of IL-1β, TNF-α, IL-6, MIP-1α, MIP-1β, ICAM-1, P-Selectin, and ROS in the Tat-stimulated TZM-bl cells, along with NF-κB, IRAK-1, and IRAK-4. Using Western blotting and luciferase assays, miR-204-5p was further shown to directly target NF-κB. Here, we report that HIV-1 Tat stimulation in cervical epithelial cells downregulates hsa-miR-204-5p, thereby activating the pro-inflammatory TLR7/NF-κB axis, highlighting its relevance to understanding mechanisms underlying cervical inflammation.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], IRAK4 (interleukin 1 receptor associated kinase 4) [NCBI Gene 51135], TLR7 (toll like receptor 7) [NCBI Gene 51284], IL1B (interleukin 1 beta) [NCBI Gene 3553], TNF (tumor necrosis factor) [NCBI Gene 7124], IL6 (interleukin 6) [NCBI Gene 3569], IL17A (interleukin 17A) [NCBI Gene 3605], CSF2 (colony stimulating factor 2) [NCBI Gene 1437], CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348], CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], SELP (selectin P) [NCBI Gene 102247510], Sele (selectin, endothelial cell) [NCBI Gene 20339], IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654]
- **Diseases:** STIs (MONDO:0021681)

## Full-text entities

- **Genes:** TAT (tyrosine aminotransferase) [NCBI Gene 6898], CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654] {aka IRAK, pelle}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, SELP (selectin P) [NCBI Gene 6403] {aka CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM}, IRAK4 (interleukin 1 receptor associated kinase 4) [NCBI Gene 51135] {aka IMD67, IPD1, IRAK-4, NY-REN-64, REN64}, MIR204 (microRNA 204) [NCBI Gene 406987] {aka MIRN204, RDICC, miRNA204, mir-204}, TLR7 (toll like receptor 7) [NCBI Gene 51284] {aka IMD74, SLEB17, TLR7-like}, SELE (selectin E) [NCBI Gene 6401] {aka CD62E, ELAM, ELAM1, ESEL, LECAM2, selectin-e}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** STIs (MESH:D012749), chronic (MESH:D002908), Cervical inflammation (MESH:D007249), HIV (MESH:D015658)
- **Chemicals:** ROS (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12839329/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12839329/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC12839329/full.md

---
Source: https://tomesphere.com/paper/PMC12839329